Drug ọgwụgwọ nke prostatic ọrịa

Drug ọgwụgwọ nke prostatitis bụ usoro ihe omume tara akpụ. Ọ na-achọ ọ bụghị nanị na a eru nhọrọ nke ngwaahịa, ma na-ọkachamara mgbe nile nlekota site a ọkachamara - na urologist.

Drug ọgwụgwọ na-agụnye ọgwụ nje ọgwụ. Usoro a na-egosi ihe ọ bụla n'ụdị (gụnyere, adịghị ala ala na-abụghị na-efe efe) ọrịa nke prostate mbụ.

N'ọnọdụ ka ukwuu, ọgwụ ndị nke oke bụ fluoroquinolones. Nke a bụ n'ihi na ha mma bioavailability na penetration n'ime prostate anụ ahụ. N'ihi ya, ọgwụ ike ga-ndinọ preparations "Ofloxacin", "Ciprofloxacin", "lomefloxacin".

Reserve ọgwụ ndị "Amoxiclav", nakwa dị ka oge a macrolides ( "Josamycin", "Azithromycin", "Kliritromitsin").

Ọ bụrụ na ọgwụ ọgwụgwọ N'ezie nke antimicrobial mmadụ adịghị emepụta ezi mmetụta, a ọgwụgwọ mmetụta na-eduzi na mkpochapu mgbu na enyemaka na urination ọrịa.

Maka enyemaka nke ihe mgbaàmà nke ihe mgbu ndị so ná ndị mgbochi mkpali ọgwụ ọjọọ na-eji. A na-agụnye, gụnyere ndị ọzọ, na-agụnye "Diclofenac ghara."

The antidepressants eji dị idobere ọgwụ. Ọ bụ ihe amamihe na-agụnye ke ọgwụ ọgwụgwọ "Fluoxetine" ( "Prozac"), "Imipramine" ( "Melipraminum").

Iji kpochapụ urination aghara predominantly Alfa-blockers na-eji. Ha usoro nke edinam dabeere na ntụrụndụ nke ezigbo muscle na prostate gland.

Dabere na-arụpụta nke comparative ọmụmụ dị iche iche Alfa-blockers nwere a yiri nrụpụta na ọrịa na urinary ọrịa. Na 50-60% nke ikpe e nwere a mma N'ihi ya, n'agbanyeghị nke selectivity nke ọgwụ ọjọọ.

Ọ ga-kwuru na nhọrọ Alfa-1a adrenergic blockers ( "Tamsulosin" "Alfuzosin") anaghị achọ nhọrọ nke onye onunu ogwu na-akpalite ole na ole oghom ihe, ọ bụ ha undoubted uru. Otú ọ dị, ọ na-emekarị hụrụ retrograde ejaculation.

Iji kwado-elu-esi na-agụnye "Finasteride" na ọgwụ ndị na-ndabere nke ihe wepụ nke hụrụ palmetto mkpụrụ. Ndị a preparations nwere ike inhibiting na enzyme 5-Alfa-reductase.

The iji "Finasteride" ihe kasị mụọ ka ụbọchị. Mgbochi nke enzyme akpalite mebiri guzobere dihydrotestosterone si testosterone. Prostate olu mbelata site nlaghachi azụ glandular anụ ahụ. Ọzọkwa, nke a na ngwá ọrụ na-ebelata likelihood nke na-emepe emepe cancer, eliminates na-enwe nsogbu urination. Oghom ngosipụta agụnye yiri arịa ọrịa na mmekọahụ ọrụ (erectile dysfunction, libido ọnụ). Mgbe ị na-ahọrọ a ọgwụ ọrịa akowa maka onwe ya naanị, nke bụ ihe dị mkpa maka ya - ezighị ezi pụta nke eji ego ma ọ bụ uru.

Drug ọgwụgwọ maka BPH na ụfọdụ ga-adịru dịkarịa ala ọnwa isii na-abịa mmetụta. N'otu oge ahụ, dị ka nnyocha ụfọdụ, "Finasteride" nwere ike ịbụ ihe ọzọ arụmọrụ maka ọrịa na ịrịba ịmụba ọnụ ọgụgụ nke prostate. N'oge ahụ, o nwere ike na-enwe mmetụta nke weakly kwupụtara na-adịghị mkpa n'ozuzu ya. Ke adianade do, ọ na-ahụ kwuru na ọgwụ na-abụghị nanị ike imeda ndị na-egbu oge mgbaàmà na mmalite nke urination, ma belata mkpa ịwa aka 50% mgbe ọgwụgwọ maka afọ anọ.

"Prostamol Uno", "Prostagut-Chiefs", "Prostaplant" nwere ike inyeaka mgbaàmà site na mbenata ha ntaramahụhụ. Ngwaahịa ndị a nwere hụrụ palmetto mkpụrụ wepụ ke ukot, adịghị akagbu abawanye na cancer onwe ya.